Leo Furcht Power - 29 Nov 2022 Form 4 Insider Report for Celcuity Inc. (CELC)

Role
Director
Signature
/s/ Eric O. Madson as Attorney-in-Fact for Leo Furcht pursuant to Power of Attorney previously filed.
Issuer symbol
CELC
Transactions as of
29 Nov 2022
Net transactions value
+$400
Form type
4
Filing time
06 Dec 2022, 15:35:00 UTC
Previous filing
19 May 2022
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CELC Common Stock Options Exercise $400 +250 $1.60* 250 29 Nov 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CELC Stock Option (right to buy) Options Exercise $0 +250 $0.000000* 0 29 Nov 2022 Common Stock 250 $1.60 Direct F1
holding CELC Stock Option (right to buy) 250 29 Nov 2022 Common Stock 250 $1.60 Direct F1
holding CELC Stock Option (right to buy) 250 29 Nov 2022 Common Stock 250 $3.60 Direct F1
holding CELC Stock Option (right to buy) 250 29 Nov 2022 Common Stock 250 $7.60 Direct F1
holding CELC Stock Option (right to buy) 250 29 Nov 2022 Common Stock 250 $7.60 Direct F1
holding CELC Stock Option (right to buy) 500 29 Nov 2022 Common Stock 500 $5.50 Direct F1
holding CELC Stock Option (right to buy) 500 29 Nov 2022 Common Stock 500 $5.50 Direct F1
holding CELC Stock Option (right to buy) 5,054 29 Nov 2022 Common Stock 5,054 $5.50 Direct F1
holding CELC Stock Option (right to buy) 25,308 29 Nov 2022 Common Stock 25,308 $5.10 Direct F1
holding CELC Stock Option (right to buy) 4,619 29 Nov 2022 Common Stock 4,619 $5.50 Direct F1
holding CELC Stock Option (right to buy) 24,449 29 Nov 2022 Common Stock 24,449 $5.50 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested.
F2 This Option will vest and become exercisable on April 30, 2023, or if earlier, the date of the Company's 2023 Annual Meeting of Stockholders.